title: Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.
abstract: Kaposi's sarcoma-associated herpesvirus (KSHV) has a significant contributory role in the development of three major human neoplastic or lymphoproliferative diseases: Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD). These diseases are associated with chromosomal instability, a hallmark of human cancer. The latency-associated nuclear antigen (LANA) encoded by KSHV plays a key role in regulating a number of cellular pathways critical for oncogenesis. KSHV LANA alone can induce the development of B-cell hyperplasia and lymphoma in mice expressing LANA. LANA also induces chromosomal instability, thus promoting oncogenesis. However, the precise mechanism underlying LANA-mediated chromosomal instability remains uncharted. Here we report that LANA promoted the induction of chromosomal instability and the formation of micronuclei and multinucleation through its interaction with one of the critical spindle checkpoint proteins, Bub1, and the resulting degradation of Bub1. This interaction occurs through the Knl and kinase domains of Bub1, identified as important for stability and degradation. These results suggest that LANA can dysregulate Bub1 activity, which leads to aberrant chromosome replication and aneuploidy, thus contributing to KSHV-mediated oncogenesis.
  
  
  OBJECTIVE
  This work represents the first set of results identifying a novel mechanism by which LANA, a latency-associated antigen encoded by KSHV, can induce the degradation of Bub1, a spindle checkpoint protein that is important for spindle checkpoint signaling and chromosome segregation. The downregulation of Bub1 mediated by LANA resulted in chromosomal instability, a hallmark of cancer. We further investigated the specific domains of Bub1 that are required for the interaction between LANA and Bub1. The results demonstrated that the Knl and kinase domains of Bub1 are required for the interaction between LANA and Bub1. In addition, we also investigated the mechanism by which LANA promoted Bub1 degradation. Our results showed that LANA interacted physically with the anaphase-promoting complex (APC/C), thus promoting the degradation of Bub1 in a ubiquitin-dependent process.
authors.affiliation: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Zhiguo
authors.initials: Z
authors.lastname: Sun
authors.affiliation: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Bingyi
authors.initials: B
authors.lastname: Xiao
authors.affiliation: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Hem Chandra
authors.initials: HC
authors.lastname: Jha
authors.affiliation: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Jie
authors.initials: J
authors.lastname: Lu
authors.affiliation: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Shuvomoy
authors.initials: S
authors.lastname: Banerjee
authors.affiliation: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA erle@upenn.edu.
authors.forename: Erle S
authors.initials: ES
authors.lastname: Robertson
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000378:metabolism*; D015153:Blotting, Western; D043171:Chromosomal Instability; D019288:Herpesvirus 8, Human / Q000502:physiology*; D006801:Humans; D047468:Immunoprecipitation; D054685:Lymphoma, Primary Effusion / Q000235:genetics / Q000378:metabolism / Q000821:virology*; D051379:Mice; D048629:Micronuclei, Chromosome-Defective; D009687:Nuclear Proteins / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D059748:Proteolysis; D012514:Sarcoma, Kaposi / Q000235:genetics / Q000378:metabolism / Q000821:virology*; D014407:Tumor Cells, Cultured; D025801:Ubiquitin / Q000378:metabolism; D054875:Ubiquitination
chemical_list: D000956:Antigens, Viral; D009687:Nuclear Proteins; D025801:Ubiquitin; C109540:latency-associated nuclear antigen; C584277:BUB1 protein, human; D017346:Protein Serine-Threonine Kinases
references.citation: Mol Biol Cell. 2001 Jul;12(7):1995-2009
references.pmid: 11451998
references.citation: PLoS Pathog. 2006 Oct;2(10):e116
references.pmid: 17069461
references.citation: N Engl J Med. 2010 Dec 30;363(27):2665-6
references.pmid: 21190461
references.citation: J Virol. 2004 Oct;78(19):10348-59
references.pmid: 15367601
references.citation: J Virol. 1996 Nov;70(11):8151-4
references.pmid: 8892944
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14554-9
references.pmid: 16983096
references.citation: EMBO J. 2005 Apr 20;24(8):1621-33
references.pmid: 15933723
references.citation: Science. 2009 Mar 13;323(5920):1477-81
references.pmid: 19286556
references.citation: Chromosoma. 1998 Dec;107(6-7):386-96
references.pmid: 9914370
references.citation: Dev Cell. 2004 Jul;7(1):45-60
references.pmid: 15239953
references.citation: J Virol. 2007 Oct;81(19):10451-9
references.pmid: 17634226
references.citation: J Virol. 2003 Jul;77(14):8019-30
references.pmid: 12829841
references.citation: Nat Med. 1995 Dec;1(12):1274-8
references.pmid: 7489408
references.citation: Virology. 2007 Aug 1;364(2):317-29
references.pmid: 17434559
references.citation: Nat Rev Cancer. 2001 Nov;1(2):109-17
references.pmid: 11905802
references.citation: J Virol. 2014 Apr;88(8):4204-17
references.pmid: 24478433
references.citation: Cancer Res. 2002 Jan 1;62(1):13-7
references.pmid: 11782350
references.citation: Cell Cycle. 2007 Jul 15;6(14):1699-704
references.pmid: 17643075
references.citation: Hum Mutat. 2003 Apr;21(4):445
references.pmid: 12655561
references.citation: Nat Rev Cancer. 2006 May;6(5):369-81
references.pmid: 16633365
references.citation: Nature. 1999 Dec 23-30;402(6764):889-94
references.pmid: 10622254
references.citation: Nat Med. 2000 Oct;6(10):1121-7
references.pmid: 11017143
references.citation: J Cell Biol. 2009 Jun 1;185(5):841-58
references.pmid: 19487456
references.citation: Cell Cycle. 2005 Oct;4(10):1435-9
references.pmid: 16138013
references.citation: J Virol. 2006 Sep;80(18):8909-19
references.pmid: 16940503
references.citation: Nature. 1997 Apr 10;386(6625):623-7
references.pmid: 9121588
references.citation: Nat Rev Mol Cell Biol. 2008 Jan;9(1):33-46
references.pmid: 18097444
references.citation: J Biol Chem. 2005 Feb 4;280(5):3862-74
references.pmid: 15525642
references.citation: Cell. 2006 Dec 1;127(5):983-97
references.pmid: 17129783
references.citation: J Virol. 1998 Oct;72(10):8309-15
references.pmid: 9733875
references.citation: Blood. 2004 Jan 1;103(1):222-8
references.pmid: 12969971
references.citation: J Virol. 2000 Oct;74(20):9637-45
references.pmid: 11000236
references.citation: Curr Top Microbiol Immunol. 2007;312:101-36
references.pmid: 17089795
references.citation: J Cell Biol. 1998 Jul 13;142(1):1-11
references.pmid: 9660858
references.citation: Blood. 1996 Oct 1;88(7):2648-54
references.pmid: 8839859
references.citation: Cancer Cell. 2009 Dec 8;16(6):475-86
references.pmid: 19962666
references.citation: J Exp Med. 1996 Jul 1;184(1):283-8
references.pmid: 8691144
references.citation: Genes Dev. 2003 Oct 1;17(19):2421-35
references.pmid: 14522947
references.citation: J Cell Sci. 2004 Mar 15;117(Pt 8):1577-89
references.pmid: 15020684
references.citation: Cancer Res. 2009 Jan 1;69(1):45-54
references.pmid: 19117986
references.citation: J Virol. 1999 Mar;73(3):2232-42
references.pmid: 9971806
references.citation: Mol Biol Cell. 2002 Jun;13(6):1977-2000
references.pmid: 12058064
references.citation: PLoS One. 2010 Sep 09;5(9):
references.pmid: 20844582
references.citation: J Cell Biol. 1998 Dec 28;143(7):1775-87
references.pmid: 9864354
references.citation: Trends Cell Biol. 2002 May;12(5):205-9
references.pmid: 12062159
references.citation: Mol Cell Biol. 2004 Nov;24(22):9786-801
references.pmid: 15509783
references.citation: Mol Cell. 2008 Nov 7;32(3):394-405
references.pmid: 18995837
references.citation: Br J Haematol. 1997 Jun;97(3):621-5
references.pmid: 9207410
references.citation: Nat Med. 1996 Mar;2(3):342-6
references.pmid: 8612236
references.citation: J Cell Biol. 2001 Jun 11;153(6):1239-50
references.pmid: 11402067
references.citation: J Virol. 1997 Aug;71(8):5915-21
references.pmid: 9223481
references.citation: Oncogene. 2004 Mar 15;23(11):2016-27
references.pmid: 15021889
references.citation: Nat Rev Mol Cell Biol. 2004 Sep;5(9):752-62
references.pmid: 15340382
references.citation: Dev Cell. 2007 Nov;13(5):663-676
references.pmid: 17981135
references.citation: J Virol. 2001 Sep;75(17):7882-92
references.pmid: 11483733
references.citation: Dev Cell. 2007 Oct;13(4):566-79
references.pmid: 17925231
references.citation: J Virol. 1998 Feb;72(2):1005-12
references.pmid: 9444993
references.citation: J Virol. 2006 Jan;80(2):697-709
references.pmid: 16378973
references.citation: Mol Cell. 2004 Nov 5;16(3):387-97
references.pmid: 15525512
references.citation: Cell Cycle. 2005 Apr;4(4):560-3
references.pmid: 15876865
references.citation: J Cell Biol. 2007 Oct 22;179(2):255-67
references.pmid: 17938250
references.citation: Cancer Res. 2005 Oct 1;65(19):8747-53
references.pmid: 16204044
references.citation: Mol Biol Cell. 2002 Sep;13(9):3029-41
references.pmid: 12221113
references.citation: J Virol. 2010 Oct;84(19):9718-32
references.pmid: 20660191
references.citation: Hum Mol Genet. 2009 Jul 15;18(14):2656-69
references.pmid: 19414482
references.citation: Blood. 2008 May 1;111(9):4731-40
references.pmid: 18199825
references.citation: J Biol Chem. 2001 Jun 22;276(25):22971-8
references.pmid: 11313352
references.citation: Cell Cycle. 2005 Feb;4(2):225-7
references.pmid: 15655355
references.citation: Nat Rev Mol Cell Biol. 2007 May;8(5):379-93
references.pmid: 17426725
references.citation: Science. 1994 Dec 16;266(5192):1865-9
references.pmid: 7997879
references.citation: J Virol. 2003 Jun;77(11):6188-96
references.pmid: 12743275
references.citation: J Cell Biol. 2004 Feb 16;164(4):535-46
references.pmid: 14769859